TY  - GEN
AU  - Nisticò,Cecilia
AU  - Bria,Emilio
AU  - Vaccaro,Vanja
AU  - Cuppone,Federica
AU  - Fornier,Monica
AU  - Sperduti,Isabella
AU  - Carpino,Armando
AU  - Izzo,Fiorentino
AU  - Tropea,Francesco
AU  - Cognetti,Francesco
AU  - Terzoli,Edmondo
TI  - Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: preliminary results of a feasibility-phase II study aimed at cardiotoxicity
SN  - 1473-5741
PY  - 2009///0428
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Epirubicin
KW  - Feasibility Studies
KW  - Female
KW  - Heart
KW  - drug effects
KW  - Humans
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Paclitaxel
KW  - Stroke Volume
KW  - Survival Rate
KW  - Trastuzumab
KW  - Treatment Outcome
KW  - Ventricular Function, Left
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1097/CAD.0b013e32831bc09b
ER  -